Metastatic prostate cancer

• Bristol Myers Squibb

  Company1 trialPhase 1/249 people

• University Health Network, Toronto

  2 trialsPhase 4376 people

• Tampere University Hospital

  2 trialsPhase 3640 people

• Swiss Cancer Institute

  1 trialPhase 31,380 people

• NCIC Clinical Trials Group

  1 trialPhase 3236 people

• University of Utah

  1 trialPhase 3200 people

• Sun Yat-sen University

  3 trialsPhase 2604 people

• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

  2 trialsPhase 2103 people

National Institute on AgingUS$157.6k

• ARTI-MPC – Activity, Risk & Therapy-Intensity in Metastatic Prostate Cancer

  National Institute on AgingUniversity of ChicagoUS$157.6k2026–2031